News
Bayer has launched a first-in-human clinical trial for 225Ac-GPC3 (BAY 3547926), a novel targeted alpha radiopharmaceutical ...
Merck has launched construction of a $1 billion biologics facility in Wilmington, set to become the U.S. production hub for ...
Microbiotica’s MB097, an oral microbiome-based therapy, shows promise in boosting immunotherapy response in melanoma patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results